Print Print    Close Close

Child deaths from acute kidney injury rises to 133 in Indonesia

Published October 28, 2022

Reuters
Fox News Flash top headlines for October 27 Video

Indonesia's health minister said on Friday that the number of children who had died from acute kidney injury (AKI) rose to 133 from the previously reported 99.

The deaths were among a total of 241 cases in 22 provinces, Budi Gunadi Sadikin said, adding that most patients were children under the age of five.

Budi on Thursday said some medicinal syrups available in Indonesia contained ethylene glycol and diethylene glycol, ingredients that have been linked to fatal AKI in children.

CALIFORNIA DOCTOR PRESCRIBED UNNECESSARY DRUGS TO OVER 1K PATIENTS

Medicinal syrup

Cough medication is being poured in this photo taken on Oct. 19, 2022.  (REUTERS/Ajeng Dinar Ulfiana/Illustration)

CLICK HERE TO GET THE FOX NEWS APP

Indonesia has temporarily banned sales and prescription of all syrup-based medications and formed an expert team comprised of local health and paediatrics officials and World Health Organization (WHO) representatives to look into the AKI spike among children.

The country's food and drug agency has also named five locally-made products which contained excessive levels of ethylene glycol and has ordered the producers to pull them out of circulation and destroy all remaining batches.

Print Print    Close Close

URL

https://www.foxnews.com/health/child-deaths-acute-kidney-injury-rises-133-indonesia

  • Home
  • Video
  • Politics
  • U.S.
  • Opinion
  • Entertainment
  • Tech
  • Science
  • Health
  • Travel
  • Lifestyle
  • World
  • Sports
  • Weather
  • Privacy
  • Terms

This material may not be published, broadcast, rewritten, or redistributed. © FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.Do Not Sell my Personal Information - New Terms of Use - FAQ